Download Gene Section ITGA11 (integrin, alpha 11) Atlas of Genetics and Cytogenetics

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Atlas of Genetics and Cytogenetics
in Oncology and Haematology
OPEN ACCESS JOURNAL AT INIST-CNRS
Gene Section
Mini Review
ITGA11 (integrin, alpha 11)
Svetlana N Popova, Donald Gullberg
Department of Biomedicine, University of Bergen, Jonas Lies vei 91, NO-5009 Bergen, Norway (SNP, DG)
Published in Atlas Database: April 2008
Online updated version: http://AtlasGeneticsOncology.org/Genes/ITGA11ID41001ch15q23.html
DOI: 10.4267/2042/44428
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 France Licence.
© 2009 Atlas of Genetics and Cytogenetics in Oncology and Haematology
the amino-terminal end with an inserted I domain
between repeats 2 and 3. The I domain consists of 195
amino acids and includes a conserved metal iondependent adhesion site motif. In addition to the metal
chelating site in the I domain, three potential divalent
cation binding motifs with the consensus sequence
DXD/ NXDXXXD are present in repeats 5-7. A total of
20 cysteines are located in the extracellular domain. Of
these, 16 are conserved in the most closely related
integrin α10- and α1-chains, and they may contribute to
intramolecular disulfide bonds. There is an inserted 22
amino acid sequence in the calf-1 domain in the stalk
region at amino acids 804-826, distinguishing α11 from
other integrin α-chains. The transmembrane region
(amino acids 1142-1164) is 23 amino acids long and is
followed by a cytoplasmic tail of 24 amino acids. The
cytoplasmic tail contains the sequence GFFRS instead
of the conserved GFFKR sequence found in all other
alpha-chains except ITGA8 - alpha 10.
Identity
Other names: HsT18964
HGNC (Hugo): ITGA11
Location: 15q23
DNA/RNA
Description
The gene contains 30 exons and 29 introns; it is
composed of a 30 nt long 5' untranslated region, a
3564-nucleotide open reading frame, a 329-nucleotide
3' noncoding sequence and a polyA tail.
Transcription
Gene analysis in silico reveals several potential splice
variants, which still remain to be validated at the RNA
level. The basal promoter is regulated by Sp1/ Sp3/ Ets1 binding sites. How occupation of these cis-binding
sites in the promoter results in a fibroblast-specific α11
expression pattern remains to be shown. One working
hypothesis is that the combined binding of Sp1 with a
specific member of the Ets family of transcription
factors contributes to the tissue-specific expression
pattern.
Expression
Protein
Localisation
Description
Membrane-bound.
Analysis of α11 protein and mRNA expression and
distribution in human and mouse embryos revealed a
restricted expression on mesenchymal non-muscle cells
in areas of highly organized interstitial colla-gen
networks.
Function
The mature α11 peptide is 1166-amino acid-long
(M.W. 145 kDa in SDS-PAGE under non-reducing
conditions), which is longer than any other currently
identified integrin α-chain (with the closest being αE,
which is composed of 1160 amino acids). The
extracellular domain contains seven FG-GAP repeats in
Atlas Genet Cytogenet Oncol Haematol. 2009; 13(3)
Integrin α11 subunit binds integrin beta 1 subunit to
form a heterodimer and function as a receptor for
interstitial collagens (with highest affinity for collagen
type I). It is involved in cell attachment, cell migration
and collagen reorganization on mesenchymal nonmuscle cells.
210
ITGA11 (integrin, alpha 11)
Popova SN, Gullberg D
Scematic structure of the I-domain containing α11 integrin
A. The integrin's α subunit primary structure, including predicted divalent cation-binding sites (Mg2 as red star, and Ca2 as gray stars) is
shown. The position of the inserted sequence of 22 amino acids in the Calf-1 domain is marked.
B. Schematic representations of straightened (active) conformations of the integrin. The arrangement of domains is based on the 3dimensional crystal structure of the αvβ3-integrin, with an I domain added between the second and third β-propeller repeats.
I-d indicates I domain; PSI, plexin/semaphorin/integrin; and TM, -tail domain of integrin β subunit.
Homology
Prognosis
The overall 5-year survival rate of lung cancer is 15%.
In NSCLC, survival rate is primarily determined by the
tumor stage, i.e. the extend of spread of tumor cells at
the time of diagnosis.
Oncogenesis
Interactions of tumor cells with the stroma play a
critical role in tumor growth, invasion, metastases,
angiogenesis, and chemoresistance. Factors derived
from the carcinoma-associated fibroblast (CAF) or
activated fibroblast can contribute to the transformation
of epithelial cells and enhance the tumorigenicity of
cancer cells possibly through paracrine secretion of
growth factors. It was recently shown that CAFs in
NSCLC express higher levels of integrin α11. One of
the factors which is affected by higher levels of
ITGA11 during tumor growth is IGF2. Higher levels of
IGF2 in turn can stimulate growth of the tumor
epithelial cells leading to tumor progression and
metastasis.
When compared with other I domain-containing
collagen-binding integrin subunits, α11 amino acid
sequence shows the highest overall identity with
integrin alpha 10 (42% identity) followed by integrin
alpha 1 (37% identity), and integrin alpha 2 (35%
identity). Of the non-I domain-containing integrins,
integrin alpha 4 and integrin alpha 9 show the highest
sequence similarity to α11. ITGA11 shows 86%
identity with mouse integrin α11 at the nucleotide level,
translating to 89% identity at the amino-acid level.
Implicated in
Lung cancer
Disease
Lung cancer, the most common cause of cancer-related
death in men and the second most common in women,
is responsible for 1.3 million deaths worldwide
annually. For treatment purposes, lung cancer is
grouped into 2 major types: small cell lung cancer
(SCLC) and non-small cell lung cancer (NSCLC). The
latter group is a heterogeneous disease which can be
classified histologically into many types, with the 4
major ones being adenocarcinomas, squamous cell
carcinoma, large cell carcinoma and adenosquamous
carcinoma. Adenocarcinoma accounts for about one
third of lung cancers, with a majority arising in the
peripheral lung tissue. In the Western world, most cases
of adenocarcinoma are associated with smoking.
However, among people who have never smoked,
adenocarcinoma is the most common form of lung
cancer. Elevated expression of ITGA11 was reported in
non-small cells carcinomas and associated with stromal
fibroblasts. The possible involvement of integrin α11 in
other types of tumor-stroma interactions remains to be
defined.
Atlas Genet Cytogenet Oncol Haematol. 2009; 13(3)
References
Velling T, Kusche-Gullberg M, Sejersen T, Gullberg D. cDNA
cloning and chromosomal localization of human alpha(11)
integrin. A collagen-binding, I domain-containing, beta(1)associated integrin alpha-chain present in muscle tissues. J
Biol Chem. 1999 Sep 3;274(36):25735-42
Tiger CF, Fougerousse F, Grundström G, Velling T, Gullberg
D. alpha11beta1 integrin is a receptor for interstitial collagens
involved in cell migration and collagen reorganization on
mesenchymal nonmuscle cells. Dev Biol. 2001 Sep
1;237(1):116-29
Wang KK, Liu N, Radulovich N, Wigle DA, Johnston MR,
Shepherd FA, Minden MD, Tsao MS. Novel candidate tumor
marker genes for lung adenocarcinoma. Oncogene. 2002 Oct
24;21(49):7598-604
Zhang WM, Popova SN, Bergman C, Velling T, Gullberg MK,
Gullberg D. Analysis of the human integrin alpha11 gene
(ITGA11) and its promoter. Matrix Biol. 2002 Oct;21(6):513-23
211
ITGA11 (integrin, alpha 11)
Popova SN, Gullberg D
Popova SN, Rodriguez-Sánchez B, Lidén A, Betsholtz C, Van
Den Bos T, Gullberg D. The mesenchymal alpha11beta1
integrin attenuates PDGF-BB-stimulated chemotaxis of
embryonic fibroblasts on collagens. Dev Biol. 2004 Jun
15;270(2):427-42
Stefanidakis M, Koivunen E. Cell-surface association between
matrix metalloproteinases and integrins: role of the complexes
in leukocyte migration and cancer progression. Blood. 2006
Sep 1;108(5):1441-50
Popova SN, Lundgren-Akerlund E, Wiig H, Gullberg D.
Physiology and pathology of collagen receptors. Acta Physiol
(Oxf). 2007 Jul;190(3):179-87
Chong IW, Chang MY, Chang HC, Yu YP, Sheu CC, Tsai JR,
Hung JY, Chou SH, Tsai MS, Hwang JJ, Lin SR. Great
potential of a panel of multiple hMTH1, SPD, ITGA11 and
COL11A1 markers for diagnosis of patients with non-small cell
lung cancer. Oncol Rep. 2006 Nov;16(5):981-8
Subramanian J, Govindan R. Lung cancer in never smokers: a
review. J Clin Oncol. 2007 Feb 10;25(5):561-70
Zhu CQ, Popova SN, Brown ER, Barsyte-Lovejoy D, Navab R,
Shih W, Li M, Lu M, Jurisica I, Penn LZ, Gullberg D, Tsao MS.
Integrin alpha 11 regulates IGF2 expression in fibroblasts to
enhance tumorigenicity of human non-small-cell lung cancer
cells. Proc Natl Acad Sci U S A. 2007 Jul 10;104(28):11754-9
Ho C, Davies AM, Lara PN Jr, Gandara DR. Second-line
treatment for advanced-stage non-small-cell lung cancer:
current and future options. Clin Lung Cancer. 2006 May;7
Suppl 4:S118-25
Lu N, Heuchel R, Barczyk M, Zhang WM, Gullberg D. Tandem
Sp1/Sp3 sites together with an Ets-1 site cooperate to mediate
alpha11 integrin chain expression in mesenchymal cells. Matrix
Biol. 2006 Mar;25(2):118-29
This article should be referenced as such:
Popova SN, Gullberg D. ITGA11 (integrin, alpha 11). Atlas
Genet Cytogenet Oncol Haematol. 2009; 13(3):210-212.
Panani AD, Roussos C. Cytogenetic and molecular aspects of
lung cancer. Cancer Lett. 2006 Jul 28;239(1):1-9
Atlas Genet Cytogenet Oncol Haematol. 2009; 13(3)
212